# Disulfiram in Patients With Metastatic Melanoma

> **NCT00256230** · PHASE1,PHASE2 · COMPLETED · sponsor: **John P. Fruehauf** · enrollment: 7 (actual)

## Conditions studied

- Stage IV Melanoma

## Interventions

- **DRUG:** Disulfiram (DSF)

## Key facts

- **NCT ID:** NCT00256230
- **Lead sponsor:** John P. Fruehauf
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2016-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00256230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00256230, "Disulfiram in Patients With Metastatic Melanoma". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00256230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*